Software & Developer Tools
Athernal Bio
United Kingdomathernalbio.com
Athernal Bio is a seed startup. 1 investor tracked.
Activeseed
seed
Stage
2021
Founded
1
Investors
About Athernal Bio
Athernal Bio is a startup founded in 2021 based in the United Kingdom. Its most recent tracked round is Seed. Brouky classifies it under Software & Developer Tools. Brouky records 1 investor associated with the company.
Athernal Bio is developing targeted immunotherapies to treat high-risk clonal haematopoiesis (CH), a widespread cancer precursor condition which can lead to acute myeloid leukaemia (AML) and other haematological cancers.
Explore Athernal Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.